Found: 8
Select item for more details and to access through your institution.
Minimal symptom expression achievement over time in generalized myasthenia gravis.
- Published in:
- Acta Neurologica Belgica, 2023, v. 123, n. 3, p. 979, doi. 10.1007/s13760-022-02162-1
- By:
- Publication type:
- Article
Japan MG registry: Chronological surveys over 10 years.
- Published in:
- Clinical & Experimental Neuroimmunology, 2023, v. 14, n. 1, p. 5, doi. 10.1111/cen3.12731
- By:
- Publication type:
- Article
Real‐world experience with eculizumab and switching to ravulizumab for generalized myasthenia gravis.
- Published in:
- Annals of Clinical & Translational Neurology, 2024, v. 11, n. 5, p. 1338, doi. 10.1002/acn3.52051
- By:
- Publication type:
- Article
Markedly upregulated serum semaphorin 4A as a novel activity marker of myasthenia gravis.
- Published in:
- Scandinavian Journal of Immunology, 2024, v. 99, n. 5, p. 1, doi. 10.1111/sji.13360
- By:
- Publication type:
- Article
Immunoadsorption apheresis versus intravenous immunoglobulin therapy for exacerbation of myasthenia gravis.
- Published in:
- Scandinavian Journal of Immunology, 2022, v. 95, n. 2, p. 1, doi. 10.1111/sji.13122
- By:
- Publication type:
- Article
Adequate Initial Dosage and Tapering Methods of Steroids to Reduce the Total Corticosteroid Dose in Myasthenia Gravis.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Identification of genotype–biochemical phenotype correlations associated with fructose 1,6-bisphosphatase deficiency.
- Published in:
- Communications Biology, 2023, v. 6, n. 1, p. 1, doi. 10.1038/s42003-023-05160-y
- By:
- Publication type:
- Article
Taste disorders and alopecia in myasthenia gravis.
- Published in:
- BMC Neurology, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12883-024-03644-w
- By:
- Publication type:
- Article